Percutaneous coronary intervention using the transradial approach reduces hospital costs by an average of $553 compared with the transfemoral route, largely due to shorter post-procedure hospital stays, according to an analysis published in the American Heart Journal. Low-, medium- and high-risk patients in the transradial group all experienced a lower rate of in-hospital bleeding complications than those who received transfemoral treatment, according to the study.

Related Summaries